Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Associated Lipodystrophy”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Post-approval studies (Phase 4)Study completedNCT03226821
What this trial is testing

Body Composition and Adipose Tissue in HIV

Who this might be right for
HIV Lipodystrophy SyndromeGrowth Hormone DeficiencyBody Composition
Columbia University 5
Not applicableStudy completedNCT01511016
What this trial is testing

Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome

Who this might be right for
HIV Lipodystrophy
Baylor College of Medicine 17
Not applicableStudy completedNCT01359917
What this trial is testing

Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
NHS Lothian 50
Early research (Phase 1)Study completedNCT01848340
What this trial is testing

Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects

Who this might be right for
HIV-associated Lipodystrophy Syndrome
ViiV Healthcare 16
Post-approval studies (Phase 4)Study completedNCT00135356
What this trial is testing

Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Bristol-Myers Squibb 219
Post-approval studies (Phase 4)Study completedNCT04340388
What this trial is testing

Contribution of Dolutegravir to Obesity and Cardiovascular Disease

Who this might be right for
HIV-1-infectionAntiviral Drug Adverse ReactionVascular Diseases+5 more
Augusta University 10
Not applicableUnknownNCT04887675
What this trial is testing

Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI

Who this might be right for
HIV I InfectionHIV Associated LipodystrophyMetabolic Syndrome+1 more
University of Novi Sad 120
Large-scale testing (Phase 3)Ended earlyNCT00148850
What this trial is testing

Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients

Who this might be right for
HIV-Associated Lipodystrophy SyndromeHIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 130
Post-approval studies (Phase 4)Study completedNCT00646984
What this trial is testing

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Hospital Clinic of Barcelona 147
Not applicableStudy completedNCT05383456
What this trial is testing

The Visceral Adiposity Measurement and Observation Study

Who this might be right for
HIVHIV-InfectionsHIV-1-infection+16 more
Theratechnologies 196
Not applicableStudy completedNCT03075332
What this trial is testing

Detraining in People Living With HIV/AIDS

Who this might be right for
Lipodystrophy Syndrome, HIVSarcopenia
Universidade Federal do Rio Grande do Norte 2
Post-approval studies (Phase 4)UnknownNCT00122226
What this trial is testing

MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
Amsterdam UMC, location VUmc 50
Large-scale testing (Phase 3)Study completedNCT00608023
What this trial is testing

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

Who this might be right for
LipodystrophyHIV Infections
Theratechnologies 263
Large-scale testing (Phase 3)Study completedNCT00123253
What this trial is testing

TH9507 in Patients With HIV-Associated Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
Theratechnologies 412
Testing effectiveness (Phase 2)Study completedNCT00461552
What this trial is testing

Therapeutic Approaches to HAART-Induced Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
University of Texas Southwestern Medical Center 23
Post-approval studies (Phase 4)Ended earlyNCT00126308
What this trial is testing

Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

Who this might be right for
HIV-Associated LipodystrophyHIV Infections
Kirby Institute 100
Not applicableStudy completedNCT02530827
What this trial is testing

Energy Expenditure of People Living With HIV/AIDS

Who this might be right for
HIV/AIDSHIV Lipodystrophy Syndrome
University of Sao Paulo General Hospital 45
Not applicableStudy completedNCT00069004
What this trial is testing

Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy SyndromeHIV Lipodystrophy Syndrome+4 more
National Institute of Allergy and Infectious Diseases (NIAID) 450
Post-approval studies (Phase 4)Ended earlyNCT00122668
What this trial is testing

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 112
Early research (Phase 1)Study completedNCT02342223
What this trial is testing

Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy

Who this might be right for
HIV Facial Lipoatrophy
Jared Jagdeo, MD, MS 20
Load More Results